This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 F Najafi , K Jamrozik & AJ Dobson (2009) Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure. Eur J Heart Fail 11, 472–479.
2 HC Bucher , P Hengstler , C Schindler , (2002) n-3 Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112, 298–304.
3 D Mozaffarian , A Ascherio , FB Hu , (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111, 157–164.
4 PL McLennan , MY Abeywardena & JS Charnock (1988) Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J 116, 709–717.
5 DS Siscovick , TE Raghunathan , I King , (1995) Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274, 1363–1367.
6 R Marchioli , F Barzi , E Bomba , (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione. Circulation 105, 1897–1903.
7 D Mozaffarian , CL Bryson , RN Lemaitre , (2005) Fish intake and risk of incident heart failure. J Am Coll Cardiol 45, 2015–2021.
9 A Nordoy , R Marchioli , H Arnesen , (2001) n-3 polyunsaturated fatty acids and cardiovascular diseases. Lipids 36, S127–S129.
11 S al Makdessi , M Brandle , M Ehrt , (1995) Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids. Mol Cell Biochem 145, 69–73.
13 S Pepe & PL McLennan (2002) Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and post-ischemic recovery of contractile function. Circulation 105, 2303–2308.
14 PL McLennan & MY Abeywardena (2005) Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. J Memb Biol 206, 85–102.
15 P McLennan , P Howe , M Abeywardena , (1996) The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 300, 83–89.
18 B Mettauer , J Zoll , A Garnier , (2006) Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflug Arch 452, 653–666.
19 JOM Ormerod , H Ashrafian & MP Frenneaux (2008) Impaired energetics in heart failure – a new therapeutic target. Pharmacol Ther 119, 264–274.
21 MK Duda , KM O'Shea , B Lei , (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 76, 303–310.
22 RA Siddiqui , SR Shaikh , R Kovacs , (2004) Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid. J Cell Biochem 92, 1141–1159.
23 EL Slee , PL McLennan , AJ Owen , (2010) Low dietary fish oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. J Lipid Res 51, 1841–1848.
24 MK Duda , KM O'Shea , A Tintinu , (2009) Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81, 319–327.
25 R Takahashi , K Okumura , T Asai , (2005) Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res 68, 213–223.
26 JH Traverse , Y Chen , M Crampton , (2001) Increased extravascular forces limit endothelium-dependent and -independent coronary vasodilation in congestive heart failure. Cardiovasc Res 52, 454–461.
27 RA Siddiqui , KA Harvey & GP Zaloga (2008) Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health. J Nutr Biochem 19, 417–437.
29 H Hallaq , A Sellmayer , TW Smith , (1990) Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci 87, 7834–7838.
30 WR Leifert , CL Dorian , A Jahangiri , (2001) Dietary fish oil prevents asynchronous contractility and alters Ca2+ handling in adult rat cardiomyocytes. J Nutr Biochem 12, 365–376.
31 PL McLennan (2001) Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36, S111–S114.
33 PC Calder (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327–335.
34 D Mozaffarian , A Geelen , IA Brouwer , (2005) Effect of fish oil on heart rate in humans – a meta-analysis of randomized controlled trials. Circulation 112, 1945–1952.
35 M Yokoyama , H Origasa , M Matsuzaki , (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis. Lancet 369, 1090–1098.
36 MY Abeywardena & JS Charnock (1995) Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat. Lipids 30, 1151–1156.
40 LA Nikolaidis , D Trumble , T Hentosz , (2004) Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MVO2 cost of catecholamines in heart failure). Eur J Heart Fail 6, 409–419.
42 SP Lubic , KM Giacomini & JC Giacomini (1995) The effects of modulation of calcium influx through the voltage-sensitive calcium-channel on cardiomyocyte hypertrophy. J Mol Cell Cardiol 27, 917–925.
43 EJ Eichhorn & MR Bristow (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94, 2285–2296.
44 S Kim , M Yoshiyama , Y Izumi , (2001) Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103, 148–154.
45 M Nagatsu , FG Spinale , M Koide , (2000) Bradycardia and the role of β-blockade in the amelioration of left ventricular dysfunction. Circulation 101, 653–659.
47 EB Levitan , A Wolk & MA Mittleman (2009) Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. Eur Heart J 30, 1495–1500.
49 S Ghio , L Scelsi , R Latini , (2010) Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 12, 1345–1353.
50 PL McLennan , AJ Owen , EL Slee , (2007) Myocardial function, ischaemia and n-3 polyunsaturated fatty acids: a membrane basis. J Cardiovasc Med 8, Suppl. 1, S15–S18.
51 D Mozaffarian & EB Rimm (2006) Fish intake, contaminants, and human health – evaluating the risks and the benefits. JAMA 296, 1885–1899.
52 AJ Owen , BA Peter-Przyborowska , AJ Hoy , (2004) Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39, 955–961.